Orphenadrine Citrate
NDC 66267-158, Orphenadrine Citrate, tablet, extended release, from NuCare Pharmaceuticals, Inc..
- Product NDC
- 66267-158
- Status
- Listed
- Labeler
- NuCare Pharmaceuticals, Inc.
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA040284
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/66267-158 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ORPHENADRINE CITRATE100 mg/1
Pharmacologic classes
Centrally-mediated Muscle Relaxation [PE]; Muscle Relaxant [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 66267-158-20 | 66267015820 | 20 TABLET, EXTENDED RELEASE in 1 BOTTLE (66267-158-20) |
| 66267-158-30 | 66267015830 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (66267-158-30) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/3eb1b1cc-ed7a-6f0f-e054-00144ff88e88
Use it
Look up 66267-158 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/66267-158 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 66267-158. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.